शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
APLLTDNSEAlembic Pharmaceuticals Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 5 Feb, 2026 · 13:57 IST

Alembic Pharma Q3 FY26 results up, Rs 42 cr Labour Codes exceptional item

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.4%Reaction day
₹795.75
prior close
₹813.00
announcement price
In-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-1.0%+2.4% vs market
Pharmaceuticals peers, median of 157sector-0.5%+1.9% vs sector

On the reaction day the stock moved 2.4 pts more than Nifty Microcap 250 and 1.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-1.2
15m
-0.6
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.4-1.0+2.4-0.5+1.9
Next day
-0.5-1.8+1.3-1.2+0.7
2d
+0.0+0.8-0.7+0.6-0.5
3d
+0.5+1.8-1.2+1.0-0.5
4d
+0.0+1.2-1.2+0.9-0.9
5d
-0.6+0.7-1.3+0.1-0.7
1w
-3.5-1.5-2.0-1.4-2.1
15d
-8.2-2.5-5.7-2.9-5.3
1m
-11.8-7.2-4.6-5.0-6.7
2m
-17.4-8.9-8.6-7.3-10.1
3m
-3.2+5.5-8.7+0.4-3.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Alembic Pharma posted Q3 FY26 consolidated revenue of Rs 1,876.31 cr, up 10.8 percent YoY. 9-month revenue rose 12.1 percent to Rs 5,497.18 cr; PAT grew 10.7 percent to Rs 472.07 cr. Q3 PAT dipped to Rs 132.97 cr due to a Rs 42.23 cr exceptional charge from Labour Codes impact on gratuity and leave. Rajkumar Baheti to be Non-Executive Director from April 1, 2026. Auditor review is unqualified.

Likely market impact

Revenue growth solid; one-time Labour Codes charge dents headline Q3 PAT. Director change is a planned handover.